Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade
Sahil Sahni(National Institutes of Health), Eytan Ruppin(Cedars-Sinai Medical Center), Matthew Nagy(National Institutes of Health), Ingrid Ferreira(Cliniques Universitaires Saint-Luc), Binbin Wang(National Cancer Institute), Kun Wang(Union Hospital), Di Wu(National Institutes of Health), Saugato Rahman Dhruba(National Institutes of Health), Sushant Patkar(National Institutes of Health)
Cited by 2
Related Papers
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813
Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis
|Experimental & Molecular Medicine|2022|321